IRX4204

· Io Therapeutics

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for IRX4204, covering 2015-05-12 to 2026-03-03. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Safety and Efficacy of IRX4204 in Mild to Moderate Plaque Psoriasis [Phase 2]